156 related articles for article (PubMed ID: 27282741)
1. New indolizine-chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation.
Moise IM; Ghinet A; Belei D; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2016 Aug; 26(15):3730-4. PubMed ID: 27282741
[TBL] [Abstract][Full Text] [Related]
2. Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activity.
Moise IM; Bîcu E; Farce A; Dubois J; Ghinet A
Bioorg Chem; 2020 Oct; 103():104184. PubMed ID: 32891861
[TBL] [Abstract][Full Text] [Related]
3. Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase.
Dumea C; Belei D; Ghinet A; Dubois J; Farce A; Bîcu E
Bioorg Med Chem Lett; 2014 Dec; 24(24):5777-5781. PubMed ID: 25453818
[TBL] [Abstract][Full Text] [Related]
4. Ultrasounds-mediated 10-seconds synthesis of chalcones as potential farnesyltransferase inhibitors.
Homerin G; Nica AS; Farce A; Dubois J; Ghinet A
Bioorg Med Chem Lett; 2020 Jun; 30(11):127149. PubMed ID: 32247731
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors.
Abuhaie CM; Ghinet A; Farce A; Dubois J; Rigo B; Bîcu E
Bioorg Med Chem Lett; 2013 Nov; 23(21):5887-92. PubMed ID: 24054122
[TBL] [Abstract][Full Text] [Related]
6. Phenothiazine-based CaaX competitive inhibitors of human farnesyltransferase bearing a cysteine, methionine, serine or valine moiety as a new family of antitumoral compounds.
Dumitriu GM; Bîcu E; Belei D; Rigo B; Dubois J; Farce A; Ghinet A
Bioorg Med Chem Lett; 2015 Oct; 25(20):4447-52. PubMed ID: 26372651
[TBL] [Abstract][Full Text] [Related]
7. Peptide chemistry applied to a new family of phenothiazine-containing inhibitors of human farnesyltransferase.
Dumitriu GM; Ghinet A; Bîcu E; Rigo B; Dubois J; Farce A; Belei D
Bioorg Med Chem Lett; 2014 Jul; 24(14):3180-5. PubMed ID: 24856060
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of a new series of phenothiazine-containing protein farnesyltransferase inhibitors.
Abuhaie CM; Ghinet A; Farce A; Dubois J; Gautret P; Rigo B; Belei D; Bîcu E
Eur J Med Chem; 2013 Jan; 59():101-10. PubMed ID: 23207411
[TBL] [Abstract][Full Text] [Related]
9. Exploring isoxazoles and pyrrolidinones decorated with the 4,6-dimethoxy-1,3,5-triazine unit as human farnesyltransferase inhibitors.
Lucescu L; Ghinet A; Shova S; Magnez R; Thuru X; Farce A; Rigo B; Belei D; Dubois J; Bîcu E
Arch Pharm (Weinheim); 2019 May; 352(5):e1800227. PubMed ID: 30947375
[TBL] [Abstract][Full Text] [Related]
10. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
Park S; Kim EH; Kim J; Kim SH; Kim I
Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
[TBL] [Abstract][Full Text] [Related]
11. A novel inhibitor of farnesyltransferase with a zinc site recognition moiety and a farnesyl group.
Tanaka A; Radwan MO; Hamasaki A; Ejima A; Obata E; Koga R; Tateishi H; Okamoto Y; Fujita M; Nakao M; Umezawa K; Tamanoi F; Otsuka M
Bioorg Med Chem Lett; 2017 Aug; 27(16):3862-3866. PubMed ID: 28666734
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I.
Qiao Y; Gao J; Qiu Y; Wu L; Guo F; Lo KK; Li D
Eur J Med Chem; 2011 Jun; 46(6):2264-73. PubMed ID: 21440964
[TBL] [Abstract][Full Text] [Related]
13. New aromatase inhibitors. Synthesis and biological activity of aryl-substituted pyrrolizine and indolizine derivatives.
Sonnet P; Dallemagne P; Guillon J; Enguehard C; Stiebing S; Tanguy J; Bureau R; Rault S; Auvray P; Moslemi S; Sourdaine P; Séralini GE
Bioorg Med Chem; 2000 May; 8(5):945-55. PubMed ID: 10882007
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives.
Hagishita S; Yamada M; Shirahase K; Okada T; Murakami Y; Ito Y; Matsuura T; Wada M; Kato T; Ueno M; Chikazawa Y; Yamada K; Ono T; Teshirogi I; Ohtani M
J Med Chem; 1996 Sep; 39(19):3636-58. PubMed ID: 8809154
[TBL] [Abstract][Full Text] [Related]
15. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and SAR study of hydroxychalcone inhibitors of human β-secretase (BACE1).
Ma L; Yang Z; Li C; Zhu Z; Shen X; Hu L
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):643-8. PubMed ID: 21222511
[TBL] [Abstract][Full Text] [Related]
17. New farnesyltransferase inhibitors in the phenothiazine series.
Belei D; Dumea C; Samson A; Farce A; Dubois J; Bîcu E; Ghinet A
Bioorg Med Chem Lett; 2012 Jul; 22(14):4517-22. PubMed ID: 22738631
[TBL] [Abstract][Full Text] [Related]
18. Chalcones and bis-chalcones: As potential α-amylase inhibitors; synthesis, in vitro screening, and molecular modelling studies.
Tajudeen Bale A; Mohammed Khan K; Salar U; Chigurupati S; Fasina T; Ali F; Kanwal ; Wadood A; Taha M; Sekhar Nanda S; Ghufran M; Perveen S
Bioorg Chem; 2018 Sep; 79():179-189. PubMed ID: 29763804
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.
Jun N; Hong G; Jun K
Bioorg Med Chem; 2007 Mar; 15(6):2396-402. PubMed ID: 17267225
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors.
Asoh K; Kohchi M; Hyoudoh I; Ohtsuka T; Masubuchi M; Kawasaki K; Ebiike H; Shiratori Y; Fukami TA; Kondoh O; Tsukaguchi T; Ishii N; Aoki Y; Shimma N; Sakaitani M
Bioorg Med Chem Lett; 2009 Mar; 19(6):1753-7. PubMed ID: 19217288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]